Item Type | Name |
Concept
|
Hepatitis B Antigens
|
Concept
|
Hepatitis D
|
Concept
|
Hepatitis B Antibodies
|
Concept
|
Hepatitis, Alcoholic
|
Concept
|
Hepatitis B
|
Concept
|
Hepatitis, Animal
|
Concept
|
Hepatitis C
|
Concept
|
Hepatitis
|
Concept
|
Hepatitis B Core Antigens
|
Concept
|
Hepatitis B Surface Antigens
|
Concept
|
Hepatitis, Viral, Human
|
Concept
|
Hepatitis B, Chronic
|
Concept
|
Hepatitis C, Chronic
|
Concept
|
Hepatitis, Autoimmune
|
Concept
|
Hepatitis B virus
|
Concept
|
Hepatitis C Antibodies
|
Academic Article
|
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection.
|
Academic Article
|
Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts.
|
Academic Article
|
Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection.
|
Academic Article
|
Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors.
|
Academic Article
|
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus.
|
Academic Article
|
Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C.
|
Academic Article
|
Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation.
|
Academic Article
|
Induction of tumor immunity and cytotoxic t lymphocyte responses using dendritic cells transduced by adenoviral vectors encoding HBsAg: comparison to protein immunization.
|
Academic Article
|
Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection.
|
Academic Article
|
Clinical and virologic outcomes of hepatitis B and C viral coinfection after liver transplantation: effect of viral hepatitis D.
|
Academic Article
|
Reversal of protein-losing enteropathy after liver transplantation in a child with idiopathic familial neonatal hepatitis.
|
Academic Article
|
MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates.
|
Academic Article
|
Cadaveric liver donors; what are the limits?
|
Academic Article
|
Late-onset renal failure after liver transplantation: role of posttransplant alcohol use.
|
Academic Article
|
Hepatic transplantation during pregnancy and the puerperium.
|
Academic Article
|
The successful use of telaprevir to treat hepatitis C recurrence after liver transplantation in an HIV co-infected patient.
|
Academic Article
|
Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin.
|
Academic Article
|
Adenovirus-mediated gene transfer to liver grafts: an improved method to maximize infectivity.
|
Academic Article
|
Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease.
|
Academic Article
|
Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients.
|
Academic Article
|
Splenic artery embolization for the treatment of refractory ascites after liver transplantation.
|
Academic Article
|
Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations.
|
Academic Article
|
[Experience of orthotopic liver transplantation from non-heart-beating donors at the University of Pittsburgh Medical Center].
|
Academic Article
|
Liver transplantation for alcoholic liver disease, viral hepatitis, and hepatic neoplasms.
|
Academic Article
|
Advances in hepatitis B virus infection.
|
Academic Article
|
Liver transplantation for hepatitis B: what have we learned and what does the future hold?
|
Academic Article
|
Hepatitis B virus (HBV) re-infection following liver transplantation: theory and practice.
|
Academic Article
|
Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation.
|
Academic Article
|
Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients: a prospective, randomized, controlled trial.
|
Academic Article
|
Hepatitis G virus coinfection in hepatitis C virus-infected liver transplant recipients.
|
Academic Article
|
Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome.
|
Academic Article
|
Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles.
|
Academic Article
|
Varicella-zoster virus hepatitis and a suggested management plan for prevention of VZV infection in adult liver transplant recipients.
|
Academic Article
|
Hemodynamic effects of inhaled nitric oxide in four patients with severe liver disease and pulmonary hypertension.
|
Academic Article
|
Outcome of liver transplantation using donors 60 to 79 years of age.
|
Academic Article
|
Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation.
|
Academic Article
|
Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis.
|
Academic Article
|
Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis.
|
Academic Article
|
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients.
|
Academic Article
|
Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis.
|
Academic Article
|
A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C.
|
Academic Article
|
Kidney transplantation for end-stage renal failure in liver transplant recipients with hepatitis C viral infection.
|
Academic Article
|
The patient with chronic hepatitis C.
|
Academic Article
|
Survival and quality of life after liver transplantation for acute alcoholic hepatitis.
|
Academic Article
|
The influence of hepatitis C virus genotypes on the outcome of liver transplantation.
|
Academic Article
|
Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus.
|
Academic Article
|
Five cases of fulminant hepatitis due to herpes simplex virus in adults.
|
Academic Article
|
Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection.
|
Academic Article
|
Infectivity of hepatic allografts with antibodies to hepatitis B virus.
|
Academic Article
|
Liver transplantation in a hemophilia patient with acquired immunodeficiency syndrome.
|
Academic Article
|
Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease.
|
Academic Article
|
Liver transplantation under cyclosporine: a decade of experience.
|
Academic Article
|
Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation.
|
Academic Article
|
World's longest surviving liver-pancreas recipient.
|
Academic Article
|
Risk stratification of allograft failure secondary to hepatitis C recurrence after liver transplantation.
|
Academic Article
|
Hemophilia Liver Transplantation Observational Study.
|
Academic Article
|
Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C.
|
Academic Article
|
Liver transplantation for alcoholic hepatitis in the United States: Excellent outcomes with profound temporal and geographic variation in frequency.
|